Literature DB >> 31756565

IL-38 is a biomarker for acute respiratory distress syndrome in humans and down-regulates Th17 differentiation in vivo.

Yu-Sen Chai1, Shi-Hui Lin2, Mu Zhang2, Liangyong Deng3, Yanqing Chen1, Ke Xie1, Chuan-Jiang Wang4, Fang Xu5.   

Abstract

Entities:  

Keywords:  Acute respiratory distress syndrome; Cytokines; IL-17A; Interleukin-38; Signal transducer and activator of transcription 3; T helper cell 17; Uncontrolled inflammation

Mesh：

Substances：

Year:  2019        PMID： 31756565     DOI： 10.1016/j.clim.2019.108315

Source DB:  PubMed          Journal:  Clin Immunol        ISSN： 1521-6616            Impact factor:   3.969


× No keyword cloud information.
  8 in total

1.  Interleukin-38 promotes skin tumorigenesis in an IL-1Rrp2-dependent manner.

Authors:  Hong Zhou; Qixiang Zhao; Chengcheng Yue; Jiadong Yu; Huaping Zheng; Jing Hu; Zhonglan Hu; Haozhou Zhang; Xiu Teng; Xiao Liu; Xiaoqiong Wei; Yuxi Zhou; Fanlian Zeng; Yan Hao; Yawen Hu; Xiaoyan Wang; Chen Zhang; Linna Gu; Wenling Wu; Yifan Zhou; Kaijun Cui; Nongyu Huang; Wei Li; Zhen Wang; Jiong Li
Journal:  EMBO Rep       Date:  2022-05-17       Impact factor: 9.071

2.  Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections.

Authors:  Xun Gao; Paul Kay Sheung Chan; Grace Chung Yan Lui; David Shu Cheong Hui; Ida Miu-Ting Chu; Xiaoyu Sun; Miranda Sin-Man Tsang; Ben Chung Lap Chan; Christopher Wai-Kei Lam; Chun-Kwok Wong
Journal:  Cell Death Dis       Date:  2021-01-07       Impact factor: 8.469

3.  Therapeutic Effect of IL-38 on Experimental Autoimmune Uveitis: Reprogrammed Immune Cell Landscape and Reduced Th17 Cell Pathogenicity.

Authors:  He Li; Lei Zhu; Rong Wang; Lihui Xie; Yuxi Chen; Runping Duan; Xiuxing Liu; Zhaohao Huang; Binyao Chen; Zhaohuai Li; Xianggui Wang; Wenru Su
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-12-01       Impact factor: 4.799

Review 4.  Immunobiological Properties and Clinical Applications of Interleukin-38 for Immune-Mediated Disorders: A Systematic Review Study.

Authors:  Abdolreza Esmaeilzadeh; Nazila Bahmaie; Elham Nouri; Mohammad Javad Hajkazemi; Maryam Zareh Rafie
Journal:  Int J Mol Sci       Date:  2021-11-21       Impact factor: 5.923

5.  Neutralization of interleukin-38 exacerbates coxsackievirus B3-induced acute myocarditis in mice.

Authors:  Yimin Xue; Mingguang Chen; Qian Chen; Tingfeng Huang; Qiaolian Fan; Fenghui Lin; Jun Ke; Feng Chen
Journal:  Virol J       Date:  2021-11-14       Impact factor: 4.099

6.  Circulating interleukin-38 concentrations in healthy adults.

Authors:  Lisa U Teufel; Dennis M de Graaf; Mihai G Netea; Charles A Dinarello; Leo A B Joosten; Rob J W Arts
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

7.  Novel insights into the role of anti-inflammatory IL-38 in immunity against infection.

Authors:  Xun Gao; Guoqiu Wu; Miranda Sin-Man Tsang; Danqi Huang; Christopher Wai-Kei Lam; Chun Kwok Wong
Journal:  Cell Mol Immunol       Date:  2022-08-16       Impact factor: 22.096

Review 8.  Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome.

Authors:  Shi-Hui Lin; Yi-Si Zhao; Dai-Xing Zhou; Fa-Chun Zhou; Fang Xu
Journal:  Genes Dis       Date:  2020-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.